Dealing with competing risks in clinical trials: How to choose the primary efficacy analysis?-Reference-Cited by-同舟云学术

Dealing with competing risks in clinical trials: How to choose the primary efficacy analysis?

Published:2018-04-29 Issue:19 Volume:37 Page:2787-2796
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Troendle James F.¹^ORCID,Leifer Eric S.¹,Kunz Lauren¹

Affiliation:

1. Office of Biostatistics Research, Division of Cardiovascular Sciences of the National Heart, Lung, and Blood Institute; NIH/DHHS; Bld RLK2 Room 9196 Bethesda MD 20892 USA

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference21 articles.

1. Design of the women's health initiative clinical trial and observational study;WHI Study Group;Control Clin Trials,1998

2. Understanding competing risks: a simulation point of view;Allignol;BMC Med Res Methodol,2011

3. Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis;Rauch;Eur J Prev Cardiol,2014

4. Cumulative incidence in competing risks data and competing risks regression analysis;Kim;Clin Cancer Res,2007

5. Analysis design of randomised clinical trials involving competing risks endpoints;Tai;Trials,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Competing Risks in Clinical Trials;Journal of the American College of Cardiology;2024-09

2. Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial;Intensive Care Medicine;2023-04-18

3. Systematic comparison of approaches to analyze clustered competing risks data;BMC Medical Research Methodology;2023-04-10

4. Postoperative survival of extrahepatic and intrahepatic cholangiocarcinoma after surgery: a population-based cohort;BMJ Open;2022-04

5. MyTEMP: Statistical Analysis Plan of a Registry-Based, Cluster-Randomized Clinical Trial;Canadian Journal of Kidney Health and Disease;2021-01